P recursor B cells differentiate into immature B lymphocytes after successfully expressing a surface IgR (IgM). Newly generated immature B cells are released from bone marrow to enter the spleen where they differentiate into long-lived mature B cells of the follicular (B2 cells) or marginal zone (MZ) 3 compartments (1) . These subsets of B lymphocytes have been described based on phenotypic, topographic, and functional characteristics, and are dependent on various factors for their generation and maintenance (2) . The mature B2 population is present in the follicular structures of the secondary lymphoid organs and its cells are characterized by their ability to recirculate, whereas MZ B cells reside in the spleen, at the red pulp/white pulp junction. Although the final differentiation of immature B cells in the spleen is a key event in the immune response, at present little is known about the molecular mechanisms regulating this process.
Two populations of splenic B cells were recently identified as precursors of follicular B2 cells. Transitional B cells of type 1 (T1) represent the recent immigrants from the bone marrow. These cells are the precursors for transitional B cells of type 2 (T2), which are actively dividing cells and are found exclusively in the primary follicles of the spleen (3). Only 5-10% of the newly generated immature B cells are selected into the pool of long-lived mature B2 cells (4, 5) . The precursors of MZ B cells are considered to be the newly formed T1 and T2 (6) or mature B cells (3) , although the nature of this process has not been fully characterized.
The program of B cell development and differentiation is largely controlled at the level of transcription initiation. This pathway is characterized by activation or down-regulation of stage and lineage-specific genes that are governed by regulatory DNA elements and combinatorial interactions of ubiquitous and cell type-specific transcription factors and cofactors. In this study, we focused on the potential role of helix-loop-helix (HLH) proteins in controlling the differentiation of immature B cells. Transcription factors with a basic HLH (bHLH) motif have been shown to be crucial for various cell differentiation processes during development of multicellular organisms (7) . The HLH domain primarily mediates homo-or heterodimerization, which is essential for DNA binding and transcription regulation. Nearly all HLH proteins possess a region of highly basic residues adjacent to the HLH domain, which facilitates binding to DNA. The E proteins are members of the highly conserved bHLH family. These proteins include the mammalian E2A, E2-2, and Hela E-box-binding proteins and the Drosophila gene product, Daughterless. E proteins were shown to be crucial for lymphocyte development. B lymphopoiesis in E2A-deficient mice is arrested at an early stage, which precedes the onset of Ig gene rearrangement (8, 9) . Transcriptional activity of the E proteins can be regulated by the expression of another class of HLH proteins, the Id family. These proteins lack a DNA-binding region, and instead function solely by dimerization with other transcriptional regulators, principally those of the bHLH family, and inhibit their functions in a dominant-negative manner (10 -12) . Id proteins play key roles in the regulation of lineage commitment, cell fate decisions, and in the timing of differentiation during lymphopoiesis (13) (14) (15) (16) (17) (18) .
In the present study, we show that Id2 is a regulator of immature B cell differentiation in the spleen.
Materials and Methods
Mice beads. To separate the IgD Ϫ , CD21 positive and negative populations, IgD Ϫ cells were divided according to their CD21 expression using the MACS system. The IgD Ϫ CD21 Ϫ cells were incubated with anti-CD45R magnetic beads and reseparated. The purity of each cell population was determined by flow cytometry using appropriate mAbs.
RNA isolation and reverse transcription
Total RNA was isolated from cells using the Tri Reagent kit (Molecular Research Center, Cincinnati, OH). Reverse transcription was conducted using Superscript II RT (Life Technologies, Grand Island, NY). The primers used included: Id1, 5Ј-GGTGAGGTCCGAGTCAGAGTATT-3Ј and 5Ј-CCATCTGGTCCCTCAGTGC-3Ј; Id2, 5Ј-CAGCCATTTCACCAGG AGAACA-3Ј and 5Ј-CAGCATTCAGTAGGCTCGTGTCA-3Ј; Id3, 5Ј-GGAGCCCGAGAGAAGGACTG-3Ј and 5Ј-GAGTTCATAATCAGGGC AGCAGA-3Ј; E2A, 5Ј-CATCCATGTCCTGCGAAGCCAC-3Ј and 5Ј-TTC TTGTCCTCTTCGGCGTCGG-3Ј; hypoxanthine guanine phosphoribosyltransferase, 5Ј-GAGGGTAGGCTGGCCTATGGCT-3Ј and 5Ј-GTTGGA TACAGGCCAGACTTTGTTG-3Ј.
Detection of Id2 and E2A by Western blotting
Cells were lysed as described previously (20) . Lysates were separated by 12% (w/v) SDS-PAGE. Alternatively, Id2 was immunoprecipitated using the anti-Id2 Ab (C-20; Santa Cruz Biotechnology, Santa Cruz, CA) as was previously described (20) . The proteins were transferred onto nitrocellulose, and probed with the anti-Id2 Ab (C-20; Santa Cruz Biotechnology) or with anti-E2A (YAE; Santa Cruz Biotechnology) followed by HRP-conjugated goat anti-rat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA).
Immunofluorescence and flow cytometry
Staining was performed on freshly isolated splenocytes as previously described (22) . The following Abs were used in experiments: RA3-6B2 anti-CD45R/B220 was obtained from Southern Biotechnology Associates (Birmingham, AL). Anti-IgD, R6-60.2 anti-IgM, 7G6 anti-CD21, S7 anti-CD43, 493 anti-mouse early B lineage mAb, and B3B4 anti-CD23 were obtained from BD PharMingen (San Diego, CA).
EMSA
Nuclear extracts were prepared as described (23) the Oct or E2A site was 32 P-labeled with Klenow fragment of DNA polymerase I for use as a probe. The oligonucleotide's sequence was described previously (23) . The Abs were preincubated with the extracts for 15 min at 4°C. The Abs used were: anti-E2A (YAE; Santa Cruz Biotechnology) and anti-CD4 (clone GK1.5; Southern Biotechnology Associates).
Proliferation of B cells
Purified B cells were cultured in 96-well plates at 2 ϫ 10 5 cells/well in RPMI medium supplemented with 10% FCS, 2 mM glutamate, 100 U/ml penicillin, 100 g/ml streptomycin, and several concentrations of LPS (Sigma-Aldrich, St. Louis, MO) or anti-IgM (Jackson ImmunoResearch Laboratories). DNA synthesis was assayed by pulsing the cultures with 1 Ci of [ 3 H]thymidine (International Chemical and Nuclear, Irvine, CA) for the last 18 h of a 2-day culture, after which the cells were harvested and counted. Assays were performed in triplicate.
5-bromo-2-deoxyuridine (BrdU) labeling of cells
Mice were fed with drinking water containing 1 mg/ml BrdU (SigmaAldrich) for 3 days. Spleen cells were then isolated and fixed with 70% ethanol. To determine the precentage of BrdU ϩ (proliferating) cells, cells were washed twice with PBS and resuspended in 0.5 ml 2N HCl/Triton X-100 and left for 20 min at room temperature. Cells were collected by centrifugation, washed, and stained with FITC-labeled anti-BrdU (BD Biosciences, Mountain View, CA) and anti-B220 (Southern Biotechnology Associates), anti-CD23, or anti-493 (BD PharMingen), and were analyzed by FACS.
Results
Because Id proteins play key roles in the regulation of lineage commitment, cell fate decisions, and in the timing of differentiation during lymphopoiesis, we have decided to determine whether Id proteins regulate differentiation of immature B cells in the spleen. We analyzed the immature (IgM ϩ IgD Ϫ ) and mature (IgM (22, 24) . IgD ϩ cells were purified from control (C57BL/6) mice. mRNA for the bHLH E2A and Id1, Id2, and Id3 proteins was analyzed in the different populations using RT-PCR. Although almost similar mRNA levels of E2A and the Id HLH Id1 and Id3 were detected in the mature and immature populations, Id2 message, which appeared in immature B cells from both control or Ii Ϫ/Ϫ cells, was dramatically decreased in the mature cells (Fig.  1A) (Fig. 1, C and D) . Thus, the HLH protein, Id2, is specifically down-regulated during the differentiation from immature to mature B2 cells.
Because Id2 is a negative regulator of transcription, we speculated that this protein might serve as an inhibitor of immature B cell differentiation by controlling transcription. To analyze whether Id2 has a physiological role in the differentiation of immature B cells, we followed B splenocyte maturation in Id2-deficient mice (Id2 Ϫ/Ϫ ). Previously, it was shown that mice lacking Id2 have a normal splenic architecture and a similar and even somewhat elevated response to T cell-dependent B cell Ags (18) . However, no detailed analysis of the various maturation stages of B cells was performed in these mice. Therefore, we studied spleen B cells from Id2 ϩ/ϩ , Id2 ϩ/Ϫ , or Id2 Ϫ/Ϫ mice for the expression of various B cell maturation markers. As can be seen in Fig. 2A , in the absence of Id2, B cells expressed higher levels of IgD and CD23, reflecting a more mature phenotype. Dot plot analysis of the spleen population revealed a shift of the mature cells to a population expressing dramatically higher levels of IgD and CD23 and a significant down-regulation of the IgD Ϫ IgM ϩ and CD23 Ϫ IgM ϩ immature populations (Fig. 2B) . Table I summarizes the percentage of the various B cell populations in the periphery of the Id2 Ϫ/ϩ and Id2 Ϫ/Ϫ mice. To determine whether the shift in the splenic population results from a defect in the differentiation of B cells in the bone marrow, early B cells in the bone marrow were analyzed. As can be seen in Fig. 2C , similar levels of the early B cell populations were detected in the bone marrow, suggesting a normal differentiation in this compartment. The only major difference was in the mature CD23 ϩ B population, which was elevated in the Id2-deficient population. These mature cells recycle from the periphery to the bone marrow and provide further indication that only the peripheral differentiation of the cells is shifted in the Id2-deficient mice.
MZ and follicular B cells constitute anatomically distinct mature B cell subsets that are located in the spleen and exhibit unique phenotypic and functional properties. The nature of MZ B cells has not been fully characterized; these cells are thought to derive from newly formed immature cells (6) , mature B cells, or T2 cells (3). We analyzed the MZ population in the Id2-deficient mice. Id2 Ϫ/Ϫ mice exhibited lower levels of the MZ (CD23 Ϫ CD21 ϩ ) population, suggesting a role for Id2 in the regulation of differentiation to MZ cells (Fig. 3A) . Moreover, analysis of the more mature B cells, the 493 negative population, revealed a reduced proportion of CD21 high cells, the MZ B cells. Thus, in the absence of Id2, there was a dramatic shift in the B2 population toward a mature B cell phenotype, while differentiation of MZ B cells was inhibited.
To further analyze the influence of Id2 expression on the MZ population, we determined the levels of Id2 message in these cells. IgD negative and positive populations were separated and the IgD Ϫ cells were reseparated according to their CD21 expression. Id2 mRNA was then analyzed in these B cell populations. As can be seen in Fig. 3B To show that the half-life of the B2 cell populations from Id2 Ϫ/ϩ or Id2 Ϫ/Ϫ mice was similar, mice were fed with BrdU for 3 days (Fig. 4A) Ϫ/Ϫ B cells had a somewhat stronger response to anti-IgM stimulation at the lower concentrations tested (Fig. 4C) , suggesting the existence of a larger population of mature cells in mice that do not express Id2.
It was previously shown that bHLH proteins encoded by the E2A gene and the early B cell development factor are required for the initiation of B lymphopoiesis (25) . To determine whether Id2 affects E2A activity in the transition between immature and mature B cell populations, we analyzed binding to the E2 box site by protein extracts from different B cell populations. Whole-cell extracts from Ii Ϫ/Ϫ mice and the IgD ϩ mature population from control mice were prepared and analyzed by EMSA with an E2 box site or octamer-binding site as a DNA probe. To determine the specificity of the binding, cold E2 box sequence (E5) was added in elevated concentrations. As can be seen in Fig. 5A , this probe specifically competed with the binding activity of a specific band in the mature population, showing that this band represents a specific E2A binding site. Moreover, incubation of this extract with anti-E2A Abs resulted in a supershift of this complex (Fig. 5A ). In addition, we found that the E2A binding activity in the immature population was dramatically reduced, whereas Oct-1 binding was unchanged (Fig. 5B) . The observed DNA binding activity is E2A-specific, as incubation of these extracts with Abs against this protein resulted in a supershifted complex, whereas Abs against CD4 did not induce any complex formation. In addition, Id2 Ϫ/Ϫ B cells exhibited a profound elevation in the DNA-binding activity to the E2 box site (Fig. 5C ), indicating that in the absence of Id2, E2A-binding activity to the DNA is dramatically elevated.
To directly show that Id2 and E2A form heterodimers, Id2 was immunoprecipitated from lysates of control and Ii Ϫ/Ϫ B cells. The proteins were analyzed by Western blot analysis with E2A Abs. As can be seen in Fig. 5D , E2A was coimmunoprecipitated together with Id2 in greater amounts from immature B cells and to a lesser extent from the total control population, indicating that the heterodimer complex exists at higher levels in immature B cells. Thus, high expression levels of Id2 down-regulates the transcription activity of E2A, which results in reduced transcription activity of the genes required for maturation.
Discussion
Early stages of B cell development take place in the bone marrow, resulting in the formation of immature B cells, which migrate to the spleen for their final differentiation into mature cells. This final maturation step is essential for B cells to become responsive to Ags and to participate in the immune response. The mechanisms regulating this final differentiation process of immature B cells are poorly understood.
In this study, we focused on the potential role of HLH proteins in the differentiation of immature B cells in the spleen. Our studies show that immature B cells express Id1, Id2, and Id3. However, Id2 message and protein are specifically down-regulated during the transition to a mature B2 population. This suggests that Id2 may play a role in the differentiation of immature B cells in the spleen.
To directly demonstrate the function of Id2 in this process, we analyzed maturation of B cells in mice lacking Id2. Our results reveal normal early B cell populations in bone marrow derived from Id2 Ϫ/Ϫ mice, suggesting that Id2 does not regulate the differentiation to pro-, pre-, and immature B cells. However, these Id2 Ϫ/Ϫ mice exhibit a different peripheral B cell population distribution. Although control spleen consists of a small proportion of Ϫ/ϩ and Id2 Ϫ/Ϫ mice proliferated similarly in response to LPS. However, these Id2 Ϫ/Ϫ cells responded more efficiently to anti-IgM stimulation, which can activate only mature B cells, in agreement with the ability of these cells to respond more strongly to SRBC (18) . Therefore, in the absence of Id2, B cells differentiate to a more mature population that does not normally exist in the control mice or represents only a small proportion of the cells. The existence of a more mature phenotype suggests that maturation of splenic B cells is down-regulated by Id2. In the absence of this control, the steady state of the cells shifts, the immature B population disappears, and the cells undergo uncontrolled differentiation, resulting in greater numbers of mature cells (Fig. 6) .
We further show that the differentiation of MZ B cells is controlled by Id2, and in Id2 Ϫ/Ϫ mice, this population is largely absent. Therefore, Id2 might serve as a bipotent regulator of differentiation in the spleen, allowing both the formation of MZ cells and controlling/limiting the differentiation to mature B2 cells. In Studies from both Drosophila and mammals support the view that the primary mechanisms through which ID proteins function is by antagonism of bHLH transcriptional regulators. The mammalian ID proteins preferentially target the ubiquitously expressed E proteins, which belong to the group of class A bHLH proteins (10 -12) . Although all ID proteins interact avidly with each of the E proteins, biochemical data indicate that individual ID proteins have distinct preferences for specific E protein targets (26, 27) . It was shown that bHLH proteins encoded by the E2A gene and the early B cell development factor are required for the initiation of B lymphopoiesis (25) , and that PAX-5 is crucial for the commitment of the cells to the B lineage (28, 29) . Our results indicate that Id2 and E2A form heterodimeric complexes that reduce the binding activity of E2A in cells of the immature stage. In the mature stage, Id2 expression is down-regulated, and this enables an up-regulation of the binding activity of E2A and transcription of essential genes required for differentiation of these mature B2 cells. Id2 controls differentiation by inhibiting E2A-dependent transcription of essential genes required for maturation and may be the heart of a mechanism regulating differentiation of immature B cells in the spleen by antagonizing E2A activity. It remains necessary to identify the genes regulated by E2A that are essential for this control. In the absence of Id2, E2A can form homodimeric complexes as early as the immature stage, a process which results in an augmented maturation of these cells to mature and more mature B cells that express higher levels of the maturation markers, and function more efficiently in the immune response. In the absence of Id2, differentiation to MZ cells is largely inhibited.
